When was Rapid Dose Therapeutics founded?

Rapid Dose Therapeutics was founded in 2008 and raised its 1st funding round 11 years after it was founded.

Where is Rapid Dose Therapeutics located?

Rapid Dose Therapeutics is headquartered in Burlington, Canada.

Who is the current CEO of Rapid Dose Therapeutics?

Mark Upsdell of Rapid Dose Therapeutics. They have also founded 1 company.

How many employees does Rapid Dose Therapeutics have?

As of Aug 31, 2026, the latest employee count at Rapid Dose Therapeutics is 9.

Is Rapid Dose Therapeutics a funded company?

Rapid Dose Therapeutics is a funded company, having raised an undisclosed amount across 7 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Oct 09, 2019.

When was the latest funding round of Rapid Dose Therapeutics?

Rapid Dose Therapeutics' latest funding was a $***** Post IPO round on Apr 24, 2024, with participation from 0 investor. Its primary sector is Neurology. In Canada, the Neurology sector has seen $179M in funding in 2026 to date.

Where does Rapid Dose Therapeutics rank among its competitors?

Rapid Dose Therapeutics ranks 309th amongst 2917 active competitors, of which 977 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of Rapid Dose Therapeutics?

Rapid Dose Therapeutics' top competitors include Jazz Pharmaceuticals, Biogen and PTC Therapeutics. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

Rapid Dose Therapeutics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of drug delivery technologies to treat the elderly, pediatrics, and neurological disorders. The company has developed proprietary QuickStrip, an oral fast-dissolving drug delivery system. It's applicable to the elderly, pediatrics, and neurological disorders. The technology mimics the blood concentrations over time to intravenous administration.

Website: rapid-dose.com
Social
Email ID: *****@rapid-dose.com
Phone Number: +1 **********

Key Metrics

Founded Year

2008

Location

Burlington, Canada

Stage

Public

Latest Funding Round

Post IPO, Apr 24, 2024, $*****

Ranked

309^th among 2917 active competitors

Employee Count

9 as on Aug 31, 2026

Investment & Acquisitions

CCB

Similar Companies

Jazz Pharmaceuticals & 601 more

Exit Details

Public

View Rapid Dose Therapeutics' full profile

Rapid Dose Therapeutics got listed on Dec 17, 2018.

Click here to take a look at Rapid Dose Therapeutics's IPO in detail

Rapid Dose Therapeutics has raised funding over 7 rounds. Its first funding round was on Oct 09, 2019.

Here is the list of recent funding rounds of Rapid Dose Therapeutics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 24, 2024	6042828	Post IPO	6930148	2959134	3181619	4179722
Feb 26, 2024	7829013	Post IPO	8720346	1369594	8691712	6224854
Jun 05, 2023	1793353	Post IPO	9677697	4502644	4176100	8753147

Access funding benchmarks and valuations. Sign up today!

View details of Rapid Dose Therapeutics's funding rounds and investors

The founders of Rapid Dose Therapeutics is Mark Upsdell. Mark Upsdell is the CEO of Rapid Dose Therapeutics.

Here are the details of Rapid Dose Therapeutics' key team members:

Mark Upsdell: Founder & CEO of Rapid Dose Therapeutics.
Contact Info: 1 email address

View details of Rapid Dose Therapeutics's Founder profiles and Board Members

Rapid Dose Therapeutics' employee count trend

Rapid Dose Therapeutics has 9 employees as of Aug 26. Here is Rapid Dose Therapeutics's employee count trend over the years:

Employee count trend for Rapid Dose Therapeutics

Uncover Rapid Dose Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Rapid Dose Therapeutics include Jazz Pharmaceuticals, Biogen and PTC Therapeutics. Here is the list of Top 10 competitors of Rapid Dose Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	81/100
2nd	Biogen 1978, Cambridge (United States), Public	Developer of therapies for neurodegenerative and immunology disorders	$80M	Berkshire Hathaway, Digital Pharma Lab & 11 others	78/100
3rd	PTC Therapeutics 1998, South Plainfield (United States), Public	Developer of small molecule drugs for the treatment of rare diseases	$248M	HBM Healthcare Investments, Credit Suisse First Boston ... & 28 others	77/100
4th	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, PSP Investments & 18 others	74/100
5th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
6th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
7th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
8th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	72/100
9th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
10th	Erasca 2018, San Diego (United States), Public	Developer of small molecule based therapeutics for cancer	$300M	Cormorant Asset Management, Arch Venture Partners ... & 13 others	71/100
309th	Rapid Dose Therapeutics 2008, Burlington (Canada), Public	Developer of drug delivery technologies to treat the elderly, pediatrics, and neurological disorders	-	-	55/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Rapid Dose Therapeutics's competitors? Click here to see the top ones

Rapid Dose Therapeutics has acquired CCB. Rapid Dose Therapeutics has not made any investments as of now.

Here is the latest report on Rapid Dose Therapeutics's sector:

Free

Neurology - Sector Report

Edition: August, 2026 (73 Pages)

View all reports related to Rapid Dose Therapeutics

Media has covered Rapid Dose Therapeutics for a total of 4 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.